These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 12270394)

  • 1. Minimal impact of CMV infection on long-term survival after liver transplantation.
    Seehofer D; Rayes N; Steinmüller T; Schmidt CA; Settmacher U; Müller AR; Neuhaus P
    Transplant Proc; 2002 Sep; 34(6):2272-3. PubMed ID: 12270394
    [No Abstract]   [Full Text] [Related]  

  • 2. Impact of cytomegalovirus infection on long-term survival after orthotopic liver transplantation.
    Hoppe L; Marroni CA; Bressane R; Lago L; Schiavo FL; Cigerza GC; Brandão AB; Zanotelli ML; Cantisani GP
    Transplant Proc; 2006; 38(6):1924-5. PubMed ID: 16908325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Posttransplant B, non-A non-B, and cytomegalovirus hepatitis increase the risk of developing chronic rejection after liver transplantation.
    Bronsther O; Mañez R; Kusne S; Irish W; Roland W; Jain A; Llull R; Demetris AJ; Starzl TE
    Transplant Proc; 1995 Feb; 27(1):1206-7. PubMed ID: 7878851
    [No Abstract]   [Full Text] [Related]  

  • 4. CMV hepatitis after liver transplantation: incidence, clinical course, and long-term follow-up.
    Seehofer D; Rayes N; Tullius SG; Schmidt CA; Neumann UP; Radke C; Settmacher U; Müller AR; Steinmüller T; Neuhaus P
    Liver Transpl; 2002 Dec; 8(12):1138-46. PubMed ID: 12474153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of cytomegalovirus for long-term survival after orthotopic liver transplantation: a prospective derivation and validation cohort analysis.
    Falagas ME; Paya C; Ruthazer R; Badley A; Patel R; Wiesner R; Griffith J; Freeman R; Rohrer R; Werner BG; Snydman DR
    Transplantation; 1998 Oct; 66(8):1020-8. PubMed ID: 9808486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CMV infection as a contributory factor for renal allograft injury and loss.
    Gerstenkorn C; Robertson H; Bell A; Shenton B; Talbot D
    Transplant Proc; 2001 Jun; 33(4):2461-2. PubMed ID: 11406211
    [No Abstract]   [Full Text] [Related]  

  • 7. HHV-6-DNAemia related to CMV-DNAemia after liver transplantation.
    Härmä M; Loginov R; Piiparinen H; Halme L; Höckerstedt K; Lautenschlager I
    Transplant Proc; 2005 Mar; 37(2):1230-2. PubMed ID: 15848678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pretransplantation risk factors for graft loss after liver transplantation in cirrhotic patients; effect of cytomegalovirus serologic status.
    Castellví JM; Xiol X; Guardiola J; Sabaté I; Roca M; Lama C; Figueras J; Jaurrieta E; Casais L
    Transpl Int; 2004 Mar; 17(3):131-7. PubMed ID: 14991083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positive donor cytomegalovirus IgG status as a major risk factor for liver allograft recipient infection.
    Neumann UP; Knoop M; Langrehr JM; Jonas S; Bechstein WO; Lang M; Neuhaus P
    Transplant Proc; 1997 Nov; 29(7):2859-60. PubMed ID: 9365592
    [No Abstract]   [Full Text] [Related]  

  • 10. Recipient factors analysis in long-term allograft survival of liver transplantation.
    Muro M; Sánchez-Bueno F; Robles R; Miras M; Ramirez P; Parrilla P
    Transplant Proc; 2002 Feb; 34(1):290-1. PubMed ID: 11959289
    [No Abstract]   [Full Text] [Related]  

  • 11. The natural course of cytomegalovirus infection and disease in renal transplant recipients.
    Hartmann A; Sagedal S; Hjelmesaeth J
    Transplantation; 2006 Jul; 82(2 Suppl):S15-7. PubMed ID: 16858268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of the recurrence of hepatitis C virus infection after liver transplantation on the long-term viability of the graft.
    Sánchez-Fueyo A; Restrepo JC; Quintó L; Bruguera M; Grande L; Sánchez-Tapias JM; Rodés J; Rimola A
    Transplantation; 2002 Jan; 73(1):56-63. PubMed ID: 11792978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of early cytomegalovirus infection after kidney transplantation on long-term graft and patient survival.
    Smedbråten YV; Sagedal S; Leivestad T; Mjøen G; Osnes K; Rollag H; Reisaeter AV; Foss A; Os I; Hartmann A
    Clin Transplant; 2014 Jan; 28(1):120-6. PubMed ID: 24351078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of cytomegalovirus infection, confirmed by pp65 antigen presence, on the development of cardiac allograft vasculopathy.
    Zakliczyński M; Krynicka-Mazurek A; Pyka Ł; Trybunia D; Nadziakiewicz P; Przybylski R; Zembala M
    Transplant Proc; 2007 Nov; 39(9):2866-9. PubMed ID: 18022004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complete withdrawal of immunosuppression in living donor liver transplantation.
    Oike F; Yokoi A; Nishimura E; Ogura Y; Fujimoto Y; Kasahara M; Kaihara S; Kiuchi T; Egawa H; Uemoto S; Tanaka K
    Transplant Proc; 2002 Aug; 34(5):1521. PubMed ID: 12176465
    [No Abstract]   [Full Text] [Related]  

  • 16. Long-term survival with heterotopic liver transplantation.
    Haberal M; Emiroğlu R; Arslan G; Karakayali H; Moray G; Bilgin N
    Transplant Proc; 2002 Sep; 34(6):2468-71. PubMed ID: 12270481
    [No Abstract]   [Full Text] [Related]  

  • 17. De novo tumors after orthotopic liver transplantation.
    Jiménez C; Rodríguez D; Marqués E; Loinaz C; Alonso O; Hernández-Vallejo G; Marín L; Rodríguez F; García I; Moreno E
    Transplant Proc; 2002 Feb; 34(1):297-8. PubMed ID: 11959293
    [No Abstract]   [Full Text] [Related]  

  • 18. A prospective study comparing safety and efficacy of mycophenolate mofetil versus azathioprine in primary liver transplant recipients.
    Fischer L; Sterneck M; Gahlemann CG; Malago M; Rogiers X; Broelsch CE
    Transplant Proc; 2000 Nov; 32(7):2125-7. PubMed ID: 11120098
    [No Abstract]   [Full Text] [Related]  

  • 19. Impact of presence of HBs antigen and anti-hepatitis C virus and anti-cytomegalovirus antibodies on transplanted kidney survival.
    Sieńko J; Wiśniewska M; Ciechanowski K; Rózański J; Domański L; Myslak M; Kamiński M; Sulikowski T; Pabisiak K; Romanowski M; Mizerski A; Tejchman K; Nowacki M; Ostrowski M; Bohatyrewicz R
    Transplant Proc; 2006; 38(1):136-8. PubMed ID: 16504685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early and delayed onset cytomegalovirus infection of liver transplant recipients in endemic areas.
    Kim JM; Kim SJ; Joh JW; Kwon CH; Shin M; Kim EY; Moon JI; Jung GO; Choi GS; Lee SK
    Transplant Proc; 2010 Apr; 42(3):884-9. PubMed ID: 20430197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.